MEAGAN MANISCALCO: Open Payments
NPI 1427505957 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 56 payments from 16 companies in 2025. Trend: 2023 $1,129 · 2024 $1,584 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 22 | $505 |
| ABBVIE INC. | 10 | $178 |
| GENZYME CORPORATION | 2 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Janssen Biotech, Inc. | 3 | $52 |
| LEO Pharma Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| UCB, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $32 |
Products named: Zoryve, RINVOQ, DUPIXENT, SKYRIZI, COSENTYX, TREMFYA, ADBRY, EBGLYSS.
Industry payments across NY — which companies pay providers there.
